Olympus Corporation of the Americas
VC Fund
Center Valley, United States
Olympus Corporation of the Americas is a VC fund in Center Valley focused on Medical and Biotechnology. At Olympus, we put a lot of good back into the world, and what we do, really matters.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Olympus Corporation of the Americas invests in
Stages Olympus Corporation of the Americas invests in
Countries Olympus Corporation of the Americas invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Investment Focus
Industry
- Medical 4 (100%)
- Biotechnology 3 (75%)
- Health Care 2 (50%)
- Life Science 1 (25%)
- Manufacturing 1 (25%)
Stage
- Grant 1 (25%)
- Series A 1 (25%)
- Series C 1 (25%)
- Private Equity 1 (25%)
Country
- United States 3 (75%)
- New Zealand 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Abigail Hunter-Syed
Director
|
Director | Total investments: 0 | Find email | |
Jakob Garrow
Head of Digital Product
|
Head of Digital Product | Total investments: 0 | Find email | |
|
Jovan Reyerson
Vice President
|
Vice President | Total investments: 0 | Find email | |
Kurt Heine
Global GI Business Leader / General Manager, Endoscopic Solutions Division
|
Global GI Business Leader / General Manager, Endoscopic Solutions Division | Total investments: 0 | Find email | |
Lyne Charron-Keller
Executive Director, Global Marketing, Respiratory Business
|
Executive Director, Global Marketing, Respiratory Business | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Swan EndoSurgical provides endoluminal surgical robotic systems that will enhance patient care everywhere. | Private Equity / Jul 25, 2025 | ||
| Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function. | $18M / Series A / Oct 28, 2024 | ||
| On Target Laboratories, LLC engages in discovering, developing, and commercializing small molecules that target specific pathological cells, when conjugated with fluorescent dyes. It offers folate and other targeting agents that target, lung, uterine, kidney, breast, colon, pancreatic, and prostate cancer cells. The company was incorporated in 2010and is based in Northbrook, Illinois. | $30M / Series C / Nov 16, 2023 | ||
| American College of Chest Physicians® (CHEST) is the industry pioneer. It helps to enhance chest medicine research, education, communication, and clinical practise. | $1M / Grant / Sep 15, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Olympus Corporation of the Americas invest in?
Olympus Corporation of the Americas invests primarily in Medical, Biotechnology and Health Care startups, most often at Grant and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Olympus Corporation of the Americas?
Public channels for Olympus Corporation of the Americas include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Olympus Corporation of the Americas?
The team at Olympus Corporation of the Americas includes Abigail Hunter-Syed (Director), Jakob Garrow (Head of Digital Product) and Jovan Reyerson (Vice President), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
